KALLIGA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kalliga, and what generic alternatives are available?
Kalliga is a drug marketed by Aurobindo Pharma and is included in one NDA.
The generic ingredient in KALLIGA is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kalliga
A generic version of KALLIGA was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
Summary for KALLIGA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Patent Applications: | 217 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KALLIGA at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for KALLIGA
US Patents and Regulatory Information for KALLIGA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma | KALLIGA | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 207081-001 | May 17, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |